UNSPSC 51302401: Amphotericin b

This classification denotes an antifungal agent with the molecular formula C47H73NO17, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7XU7A7DROE. European Medicines Agency schedules amphotericin b in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05486MIG. The term AMPHOTERICIN B is an International Non-Proprietary Name or INN. Most nations schedule amphotericin b under HS 29419000 and SITC 54139. As of Q4 2014, AMPHOTERICIN B remains the US FDA Preferred Term for this commodity.

Amphotericin b bears US NLM identifiers UMLS ID C0002679 and NCI Concept Code C238. SMILES: CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O.

UNSPSC 51302401 Amphotericin B is a Commodity code that in recent state and local procurement activity bears little relationship to its nominal scope. The two most recent opportunities posted under this code — the City of Austin's IFB for liquid aluminum sulfate (alum) for wastewater treatment and the City of Tampa's ITB for medical aid supplies (antiseptic sprays, hydrogen peroxide, aspirin, bandages, emergency blankets, and first aid kits) — are fundamentally misaligned with amphotericin B, a specialized antifungal pharmaceutical. The Austin opportunity targets chemical treatment of wastewater streams at municipal water facilities; the Tampa opportunity targets routine first aid and emergency medical supplies for fire rescue operations. Neither involves antifungal pharmaceuticals or pharmaceutical procurement at the scale and specificity the code name implies. This mislabeling suggests the code may be applied inconsistently by issuing bodies or that the opportunities have been tagged incorrectly in the source system.

Without opportunities actually soliciting amphotericin B or related antifungal pharmaceuticals under this code in the recent record, no meaningful geographic or issuing-body pattern emerges. The code shows activity only in Texas (Austin) and Florida (Tampa), but both records represent off-code procurement noise rather than a legitimate market signal for amphotericin B vendors. A business development professional evaluating this code should treat it as currently inactive for its intended scope and flag the tagging error with procurement offices before investing pursuit effort.